FDA Investigator

Barbara J Wilimczyk-Macri

Latest inspection on record: New Brunswick, United States, March 2023 · records back to 2009

Human DrugsAnimal Drugs & FeedsMedical Devices & Rad Health

FDA inspection record · Last updated July 12, 2026

Overview

  • 87 inspections across 72 sites are on record.
  • 233 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2023-03-24.

At a glance

Inspections

87

Sites

72

Observations

233

Career since

Jun 2009

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP.24 Mar 2023Human DrugsOn file
Raritan Pharmaceuticals, Inc.20 Oct 2016Human DrugsView 483 →
Pliva Hrvatska d.o.o.20 Sep 2016Medical Devices & Rad HealthOn file
Przedsiebiorstwo Produkcyjno Wdrozeniowe Ifotam Sp ZOO Zakla9 Sep 2016Human Drugs
PharMEDium Services, LLC26 May 2016Human DrugsView 483 →

Sites inspected

Raritan Pharmaceuticals, Inc.East Brunswick, United States1 insp.
Pliva Hrvatska d.o.o.Zagreb, Croatia1 insp.
PharMEDium Services, LLCDayton, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Barbara J Wilimczyk-Macri's 233 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site